InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by MANZO MICHAEL P., Vice-Président de l'Ingénierie. Officer active across 1 company, notably Eyegate Pharmaceuticals INC. Aggregated, 8 disclosures have been logged. History available since 4 May 2021. The latest transaction was filed on 3 August 2021 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
65 shares@ US$2.403.8% of flowCommon StockSEC:0001104659-21-100199:0
65 shares@ US$2.403.8% of flowCommon StockSEC:0001104659-21-100199
160 shares@ US$3.7014.6% of flowCommon StockSEC:0001104659-21-089446
160 shares@ US$3.7014.6% of flowCommon StockSEC:0001104659-21-089446:0
155 shares@ US$4.1915.7% of flowCommon StockSEC:0001104659-21-077764:0
155 shares@ US$4.1915.7% of flowCommon StockSEC:0001104659-21-077764
158 shares@ US$4.1315.9% of flowCommon StockSEC:0001104659-21-061948:0
158 shares@ US$4.1315.9% of flowCommon StockSEC:0001104659-21-061948
8 of 8 declarations
About MANZO MICHAEL P.
Michael P. Manzo is the Vice President of Engineering at Eyegate Pharmaceuticals Inc. He is responsible for leading engineering and research and development teams. His technical expertise and project management experience are essential for developing new therapeutic solutions within the company.
